Q & M Dental Group (Singapore) Limited (SGX:QC7)
0.5600
0.00 (0.00%)
At close: Mar 20, 2026
SGX:QC7 Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 195 | 180.67 | 182.72 | 181.21 | 205.6 |
Other Revenue | 2.22 | - | - | - | - |
| 197.23 | 180.67 | 182.72 | 181.21 | 205.6 | |
Revenue Growth (YoY) | 9.16% | -1.12% | 0.83% | -11.86% | 49.40% |
Cost of Revenue | 140.56 | 128.35 | 132.21 | 134.91 | 135.97 |
Gross Profit | 56.67 | 52.32 | 50.52 | 46.3 | 69.63 |
Selling, General & Admin | - | - | 0.23 | 0.27 | 0.35 |
Other Operating Expenses | 14.33 | 10.58 | 10.59 | 9.94 | 10.24 |
Operating Expenses | 34.04 | 28.55 | 28.59 | 27.27 | 24.16 |
Operating Income | 22.63 | 23.77 | 21.92 | 19.03 | 45.47 |
Interest Expense | -6.44 | -5.37 | -5.66 | -3.91 | -3.02 |
Interest & Investment Income | 0.56 | - | 0.06 | 0.03 | 0.01 |
Earnings From Equity Investments | -0.1 | 0.51 | -0.08 | -0.54 | -0.47 |
Currency Exchange Gain (Loss) | 0.2 | 0.06 | -0.09 | -0.01 | -0.04 |
Other Non Operating Income (Expenses) | - | 1.04 | - | -0.09 | -0.08 |
EBT Excluding Unusual Items | 16.84 | 20 | 16.16 | 14.51 | 41.88 |
Impairment of Goodwill | - | -2.54 | -2.39 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 4.37 |
Gain (Loss) on Sale of Assets | -3.82 | 0.41 | 0.08 | 0.03 | 0.01 |
Asset Writedown | -0.84 | -3.12 | -0.18 | -0.26 | -0.2 |
Other Unusual Items | - | - | - | - | 0.6 |
Pretax Income | 12.19 | 14.75 | 13.66 | 14.28 | 46.65 |
Income Tax Expense | 2.27 | 1.69 | 2.59 | 2.42 | 7.3 |
Earnings From Continuing Operations | 9.92 | 13.07 | 11.07 | 11.86 | 39.36 |
Minority Interest in Earnings | -0.61 | 1.57 | 0.44 | -0.55 | -8.89 |
Net Income | 9.31 | 14.64 | 11.52 | 11.31 | 30.47 |
Net Income to Common | 9.31 | 14.64 | 11.52 | 11.31 | 30.47 |
Net Income Growth | -36.38% | 27.09% | 1.84% | -62.89% | 54.67% |
Shares Outstanding (Basic) | 947 | 947 | 946 | 941 | 944 |
Shares Outstanding (Diluted) | 947 | 947 | 946 | 941 | 944 |
Shares Change (YoY) | -0.07% | 0.10% | 0.60% | -0.31% | -0.07% |
EPS (Basic) | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 |
EPS (Diluted) | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 |
EPS Growth | -36.57% | 26.97% | 1.40% | -62.83% | 54.77% |
Free Cash Flow | 31.86 | 32.15 | 27.52 | 24.24 | 43 |
Free Cash Flow Per Share | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 |
Dividend Per Share | 0.008 | 0.011 | 0.007 | 0.010 | 0.036 |
Dividend Growth | -25.45% | 59.42% | -31.00% | -72.22% | 380.00% |
Gross Margin | 28.73% | 28.96% | 27.65% | 25.55% | 33.87% |
Operating Margin | 11.47% | 13.16% | 12.00% | 10.50% | 22.11% |
Profit Margin | 4.72% | 8.10% | 6.30% | 6.24% | 14.82% |
Free Cash Flow Margin | 16.15% | 17.79% | 15.06% | 13.38% | 20.91% |
EBITDA | 28.1 | 28.74 | 26.67 | 23.68 | 49.59 |
EBITDA Margin | 14.25% | 15.90% | 14.60% | 13.07% | 24.12% |
D&A For EBITDA | 5.48 | 4.96 | 4.75 | 4.66 | 4.13 |
EBIT | 22.63 | 23.77 | 21.92 | 19.03 | 45.47 |
EBIT Margin | 11.47% | 13.16% | 12.00% | 10.50% | 22.11% |
Effective Tax Rate | 18.60% | 11.43% | 18.96% | 16.96% | 15.64% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.